Publication Information

{'id': 'https://openalex.org/W2403984562', 'doi': None, 'title': 'Methotrexate in the treatment of psoriasis.', 'display_name': 'Methotrexate in the treatment of psoriasis.', 'publication_year': 1999, 'publication_date': '1999-11-01', 'ids': {'openalex': 'https://openalex.org/W2403984562', 'mag': '2403984562', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/10582158'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/10582158', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5062214148', 'display_name': 'Bright Rd', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Bright Rd', 'raw_affiliation_strings': ['Psoriasis Research Institute, Palo Alto, California 94301, USA.'], 'affiliations': [{'raw_affiliation_string': 'Psoriasis Research Institute, Palo Alto, California 94301, USA.', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5062214148'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.106, 'has_fulltext': False, 'cited_by_count': 19, 'citation_normalized_percentile': {'value': 0.624241, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 83, 'max': 84}, 'biblio': {'volume': '64', 'issue': '5', 'first_page': '332', 'last_page': '4'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10469', 'display_name': 'Psoriasis: Treatment and Pathogenesis', 'score': 0.9533, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10469', 'display_name': 'Psoriasis: Treatment and Pathogenesis', 'score': 0.9533, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/antifolate', 'display_name': 'Antifolate', 'score': 0.6357005}, {'id': 'https://openalex.org/keywords/refractory', 'display_name': 'Refractory (planetary science)', 'score': 0.572022}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9504399}, {'id': 'https://openalex.org/C2780564577', 'wikidata': 'https://www.wikidata.org/wiki/Q179945', 'display_name': 'Psoriasis', 'level': 2, 'score': 0.94543827}, {'id': 'https://openalex.org/C2781059491', 'wikidata': 'https://www.wikidata.org/wiki/Q422232', 'display_name': 'Methotrexate', 'level': 2, 'score': 0.92625}, {'id': 'https://openalex.org/C2778397455', 'wikidata': 'https://www.wikidata.org/wiki/Q50429865', 'display_name': 'Antimetabolite', 'level': 3, 'score': 0.9124423}, {'id': 'https://openalex.org/C2781382166', 'wikidata': 'https://www.wikidata.org/wiki/Q50573407', 'display_name': 'Antifolate', 'level': 4, 'score': 0.6357005}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.6111857}, {'id': 'https://openalex.org/C142424586', 'wikidata': 'https://www.wikidata.org/wiki/Q7307572', 'display_name': 'Refractory (planetary science)', 'level': 2, 'score': 0.572022}, {'id': 'https://openalex.org/C16005928', 'wikidata': 'https://www.wikidata.org/wiki/Q171171', 'display_name': 'Dermatology', 'level': 1, 'score': 0.526446}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.44547206}, {'id': 'https://openalex.org/C177713679', 'wikidata': 'https://www.wikidata.org/wiki/Q679690', 'display_name': 'Intensive care medicine', 'level': 1, 'score': 0.36704537}, {'id': 'https://openalex.org/C141071460', 'wikidata': 'https://www.wikidata.org/wiki/Q40821', 'display_name': 'Surgery', 'level': 1, 'score': 0.3043602}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.27957064}, {'id': 'https://openalex.org/C121332964', 'wikidata': 'https://www.wikidata.org/wiki/Q413', 'display_name': 'Physics', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C87355193', 'wikidata': 'https://www.wikidata.org/wiki/Q411', 'display_name': 'Astrobiology', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D003879', 'descriptor_name': 'Dermatologic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D008727', 'descriptor_name': 'Methotrexate', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D011565', 'descriptor_name': 'Psoriasis', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000075202', 'descriptor_name': 'Contraindications', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003879', 'descriptor_name': 'Dermatologic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003879', 'descriptor_name': 'Dermatologic Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008727', 'descriptor_name': 'Methotrexate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008727', 'descriptor_name': 'Methotrexate', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D011565', 'descriptor_name': 'Psoriasis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/10582158', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.86, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2522961445', 'https://openalex.org/W2466597391', 'https://openalex.org/W2418690042', 'https://openalex.org/W2403984562', 'https://openalex.org/W2188912574', 'https://openalex.org/W2167696599', 'https://openalex.org/W2007071143', 'https://openalex.org/W2001582869', 'https://openalex.org/W1985511923', 'https://openalex.org/W1966616648'], 'abstract_inverted_index': {'Methotrexate': [0, 83], 'is': [1, 84], 'an': [2], 'important': [3], 'drug': [4, 20, 68], 'in': [5, 32, 34, 96], 'the': [6, 53, 67, 77, 97], 'armamentarium': [7], 'available': [8], 'to': [9, 11, 16, 29, 39, 71, 74], 'physicians': [10], 'treat': [12], 'patients': [13, 101], 'with': [14, 91], 'moderate': [15], 'severe': [17], 'psoriasis.': [18], 'The': [19], 'has': [21, 27, 47, 52], 'a': [22], '40-year': [23], 'track': [24], 'record': [25], 'and': [26, 58, 66, 93], 'proven': [28, 48], 'be': [30, 63], 'effective': [31], 'cases': [33], 'psoriasis': [35, 92], 'that': [36], 'are': [37], 'refractory': [38], 'other': [40], 'intense': [41], 'forms': [42], 'of': [43, 79, 99], 'treatment.': [44], 'While': [45], 'it': [46], 'efficacy,': [49], 'methotrexate': [50], 'also': [51], 'potential': [54], 'for': [55], 'both': [56], 'acute': [57], 'chronic': [59], 'toxicity.': [60], 'Patients': [61], 'must': [62], 'carefully': [64], 'selected': [65], 'administered': [69], 'according': [70], 'specific': [72], 'guidelines': [73], 'guard': [75], 'against': [76], 'development': [78], 'serious': [80], 'side': [81], 'effects.': [82], 'best': [85], 'used': [86], 'by': [87], 'individuals': [88], 'very': [89], 'familiar': [90], 'equally': [94], 'well-versed': [95], 'complexities': [98], 'managing': [100], 'on': [102], 'antimetabolite': [103], 'therapy.': [104]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2403984562', 'counts_by_year': [{'year': 2021, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 1}, {'year': 2018, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-12-17T14:53:02.192836', 'created_date': '2016-06-24'}